Unnamed: 0,title,date,stock,sentiment
228212.0,Chembio Diagnostics shares are trading higher after the company received FDA 510(k) clearance for its DPP Zika IgM systems.,2020-06-08 09:06:00-04:00,CEMI,positive
228213.0,Chembio Diagnostics Receives FDA 510(k) Clearance For DPP Zika IgM System,2020-06-08 08:03:00-04:00,CEMI,neutral
228214.0,"Benzinga's Top Upgrades, Downgrades For May 26, 2020",2020-05-26 09:42:00-04:00,CEMI,positive
228215.0,"Baird Initiates Coverage On Chembio Diagnostics with Outperform Rating, Announces Price Target of $21",2020-05-26 06:26:00-04:00,CEMI,neutral
228216.0,Chembio Diagnostics shares are trading higher after the company announced it signed a deal with Thermo Fisher to distribute its Chembio's coronavirus test.,2020-05-18 08:49:00-04:00,CEMI,positive
228217.0,Chembio Diagnostics Signs a Deal with Thermo Fisher to Distribute Chembio's COVID-19 Test,2020-05-18 07:29:00-04:00,CEMI,neutral
228218.0,Chembio Diagnostics Prices ~2.34M Share Common Stock Offering At $11.75/Share,2020-05-07 08:56:00-04:00,CEMI,positive
228219.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,CEMI,negative
228220.0,Chembio Diagnostics Announces A Common Stock Offering; No Details Disclosed,2020-05-06 16:17:00-04:00,CEMI,negative
228221.0,70 Biggest Movers From Yesterday,2020-05-06 05:26:00-04:00,CEMI,neutral
228222.0,51 Stocks Moving In Tuesday's Mid-Day Session,2020-05-05 12:22:00-04:00,CEMI,neutral
228223.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,CEMI,positive
228224.0,28 Stocks Moving in Tuesday's Pre-Market Session,2020-05-05 07:16:00-04:00,CEMI,neutral
228225.0,Chembio Diagnostics shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.,2020-05-04 16:27:00-04:00,CEMI,neutral
228226.0,"Chembio Diagnostics Q1 EPS $(0.290) Misses $(0.230) Estimate, Sales $6.900M Miss $7.730M Estimate",2020-05-04 16:20:00-04:00,CEMI,negative
228227.0,Chembio Diagnostics Attains CE Marking For DPP Coronavirus COVID-19 System For IgG And IgM Antibodies,2020-05-04 16:04:00-04:00,CEMI,neutral
228228.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,CEMI,neutral
228229.0,82 Biggest Movers From Yesterday,2020-04-29 04:30:00-04:00,CEMI,neutral
228230.0,56 Stocks Moving In Tuesday's Mid-Day Session,2020-04-28 12:27:00-04:00,CEMI,neutral
228231.0,34 Stocks Moving in Tuesday's Pre-Market Session,2020-04-28 07:16:00-04:00,CEMI,neutral
228232.0,96 Biggest Movers From Yesterday,2020-04-28 04:22:00-04:00,CEMI,neutral
228233.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,CEMI,positive
228234.0,"The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives",2020-04-21 08:19:00-04:00,CEMI,positive
228235.0,"Chembio Diagnostics On April 20, Co Through Unit Entered Into Loan Agreement With HSBC Bank USA, National Association, Refereed To As PPP Loan; Co. To Receive About $2.98M, Which Will Mature On April 20, 2022",2020-04-21 06:24:00-04:00,CEMI,positive
228236.0,78 Biggest Movers From Yesterday,2020-04-21 04:32:00-04:00,CEMI,neutral
228237.0,54 Stocks Moving In Monday's Mid-Day Session,2020-04-20 12:43:00-04:00,CEMI,neutral
228238.0,Stocks That Hit 52-Week Highs On Monday,2020-04-20 10:25:00-04:00,CEMI,neutral
228239.0,35 Stocks Moving in Monday's Pre-Market Session,2020-04-20 07:20:00-04:00,CEMI,neutral
228240.0,58 Stocks Moving In Friday's Mid-Day Session,2020-04-17 12:31:00-04:00,CEMI,neutral
228241.0,"The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement",2020-04-17 07:35:00-04:00,CEMI,positive
228242.0,70 Biggest Movers From Yesterday,2020-04-17 04:53:00-04:00,CEMI,neutral
228243.0,52 Stocks Moving In Thursday's Mid-Day Session,2020-04-16 12:58:00-04:00,CEMI,neutral
228244.0,52 Stocks Moving In Thursday's Mid-Day Session,2020-04-16 12:57:00-04:00,CEMI,neutral
228245.0,"Canaccord Genuity Maintains Buy on Chembio Diagnostics, Raises Price Target to $12",2020-04-16 11:10:00-04:00,CEMI,neutral
228246.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-16 10:19:00-04:00,CEMI,neutral
228247.0,Mid-Morning Market Update: Markets Mostly Lower; Morgan Stanley Misses Q1 Expectations,2020-04-16 10:13:00-04:00,CEMI,negative
228248.0,"Benzinga Pro's Top 5 Stocks To Watch For Thurs., Apr. 16, 2020: BBY, PLT, DCAR, TBLT, CEMI",2020-04-16 07:57:00-04:00,CEMI,positive
228249.0,"Chembio Reports Receives Emergency Use Authorization For DPP Coronavirus Infection System For IgG, IgM Antibodies; Says First Shipments Of Serological Test Have Been Released",2020-04-15 09:27:00-04:00,CEMI,negative
228250.0,78 Biggest Movers From Yesterday,2020-04-15 04:45:00-04:00,CEMI,neutral
228251.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-04-14 12:52:00-04:00,CEMI,neutral
228252.0,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",2020-04-14 07:59:00-04:00,CEMI,negative
228253.0,86 Biggest Movers From Yesterday,2020-04-14 05:19:00-04:00,CEMI,negative
228254.0,63 Stocks Moving In Monday's Mid-Day Session,2020-04-13 12:35:00-04:00,CEMI,neutral
228255.0,Stocks That Hit 52-Week Highs On Monday,2020-04-13 10:25:00-04:00,CEMI,neutral
228256.0,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street,2020-04-13 05:50:00-04:00,CEMI,negative
228257.0,"5 Stocks To Watch For April 13, 2020",2020-04-13 04:58:00-04:00,CEMI,neutral
228258.0,Chembio Diagnostics shares are trading higher after the company reported collaboration with Stony Brook Medicine to identify coronavirus survivors.,2020-04-09 16:15:00-04:00,CEMI,positive
228259.0,Chembio Reports Collaboration With Stony Brook Medicine To Identify Coronavirus Survivors,2020-04-09 16:06:00-04:00,CEMI,neutral
228260.0,Chembio Receives Second UNICEF Order for $1.5M,2020-04-08 08:06:00-04:00,CEMI,neutral
228261.0,84 Biggest Movers From Yesterday,2020-04-07 05:47:00-04:00,CEMI,neutral
228262.0,72 Biggest Movers From Yesterday,2020-04-02 04:23:00-04:00,CEMI,neutral
228263.0,Mid-Afternoon Market Update: Dow Tumbles 800 Points; Chembio Diagnostics Shares Spike Higher,2020-04-01 14:31:00-04:00,CEMI,positive
228264.0,54 Stocks Moving In Wednesday's Mid-Day Session,2020-04-01 12:30:00-04:00,CEMI,neutral
228265.0,Mid-Day Market Update: ProPetro Slides After Q4 Results; InflaRx Shares Jump,2020-04-01 12:11:00-04:00,CEMI,positive
228266.0,Mid-Morning Market Update: Markets Open Lower; UniFirstTops Q2 Estimates,2020-04-01 10:26:00-04:00,CEMI,negative
228267.0,"Benchmark Maintains Speculative Buy on Chembio Diagnostics, Raises Price Target to $7",2020-04-01 08:03:00-04:00,CEMI,positive
228268.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-04-01 07:45:00-04:00,CEMI,neutral
228269.0,"The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests",2020-04-01 07:38:00-04:00,CEMI,neutral
228270.0,31 Stocks Moving in Wednesday's Pre-Market Session,2020-04-01 07:18:00-04:00,CEMI,neutral
228271.0,Chembio Announces Launch of 15 Minute DPP COVID-19 Serological Point-of-Care Test,2020-04-01 05:33:00-04:00,CEMI,neutral
228272.0,75 Stocks Moving In Tuesday's Mid-Day Session,2020-03-24 12:50:00-04:00,CEMI,neutral
228273.0,105 Biggest Movers From Friday,2020-03-23 05:21:00-04:00,CEMI,neutral
228274.0,70 Stocks Moving In Friday's Mid-Day Session,2020-03-20 12:02:00-04:00,CEMI,neutral
228275.0,Chembio Diagnostics shares are trading higher after the company received a $4 million order from Bio-Manguinhos for the purchase of the company's DPP coronavirus infection system.,2020-03-20 09:56:00-04:00,CEMI,positive
228276.0,Chembio Diagnostics Wins $4M Purchase Order From Bio-Manguinhos For Production Of DPP Coronavirus Infection System In Brazil,2020-03-20 08:03:00-04:00,CEMI,positive
228277.0,96 Stocks Moving In Wednesday's Mid-Day Session,2020-03-18 12:39:00-04:00,CEMI,neutral
228278.0,88 Stocks Moving In Friday's Mid-Day Session,2020-03-13 12:38:00-04:00,CEMI,neutral
228279.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,CEMI,negative
228280.0,30 Stocks Moving in Friday's Pre-Market Session,2020-03-13 07:32:00-04:00,CEMI,neutral
228281.0,136 Biggest Movers From Yesterday,2020-03-13 05:20:00-04:00,CEMI,neutral
228282.0,Chembio Diagnostics Appoints Richard Eberly As President & Chief Executive Officer,2020-03-12 16:46:00-04:00,CEMI,neutral
228283.0,"Chembio Diagnostics Q4 EPS $(0.23) Beats $(0.24) Estimate, Sales $6.9M Miss $8.55M Estimate",2020-03-12 16:31:00-04:00,CEMI,negative
228284.0,90 Stocks Moving In Thursday's Mid-Day Session,2020-03-12 12:21:00-04:00,CEMI,neutral
228285.0,Mid-Day Market Update: Crude Oil Down Over 5%; Alpha Pro Tech Shares Spike Higher,2020-03-12 12:07:00-04:00,CEMI,negative
228286.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,CEMI,negative
228287.0,Chembio Diagnostics And Takeda Pharmaceutical Complete Feasibility Study,2020-03-11 16:14:00-04:00,CEMI,neutral
228288.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,CEMI,positive
228289.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,CEMI,negative
228290.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,CEMI,negative
228291.0,"The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study",2020-03-06 08:49:00-05:00,CEMI,negative
228292.0,"Benchmark Maintains Speculative Buy on Chembio Diagnostics, Lowers Price Target to $5",2020-03-04 07:28:00-05:00,CEMI,neutral
228293.0,85 Biggest Movers From Yesterday,2020-03-04 05:04:00-05:00,CEMI,neutral
228294.0,Chembio Diagnostics Offers Update On FDA Premarket Approval Application For DPP HIV-Syphilis Assay System: FDA Confirmed Syphilis Arm Study Was Acceptable,2020-03-03 08:33:00-05:00,CEMI,positive
228295.0,140 Biggest Movers From Friday,2020-03-02 04:43:00-05:00,CEMI,neutral
228296.0,86 Stocks Moving In Friday's Mid-Day Session,2020-02-28 12:19:00-05:00,CEMI,negative
228297.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,CEMI,neutral
228298.0,100 Stocks Moving In Thursday's Mid-Day Session,2020-02-27 12:24:00-05:00,CEMI,neutral
228299.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,CEMI,negative
228300.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,CEMI,negative
228301.0,Chembio Diagnostics Receives $1.5M UNICEF Order For Multiplex Zika Systems,2020-02-12 07:46:00-05:00,CEMI,neutral
228302.0,21 Diagnostics & Research Stocks Moving In Thursday's Session,2020-01-23 12:53:00-05:00,CEMI,neutral
228303.0,55 Biggest Movers From Friday,2020-01-13 05:17:00-05:00,CEMI,neutral
228304.0,40 Stocks Moving In Friday's Mid-Day Session,2020-01-10 12:29:00-05:00,CEMI,neutral
228305.0,"Chembio Diagnostics Reports Pres, CEO John Sperzel To Resign; Gail Page Named Interim CEO",2020-01-09 16:16:00-05:00,CEMI,negative
228306.0,53 Biggest Movers From Friday,2020-01-06 05:30:00-05:00,CEMI,neutral
228307.0,30 Stocks Moving In Friday's Mid-Day Session,2020-01-03 12:29:00-05:00,CEMI,neutral
228308.0,"The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger",2020-01-03 07:55:00-05:00,CEMI,negative
228309.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,CEMI,neutral
228310.0,Chembio Diagnostics Says Anticipates FDA Approval Of DPP HIV-Syphilis Test During Q1 Of 2020,2020-01-02 16:10:00-05:00,CEMI,positive
228311.0,Stocks That Hit 52-Week Lows On Thursday,2019-11-14 11:11:00-05:00,CEMI,negative
228312.0,"Chembio Diagnostics Q3 EPS $(0.22) Misses $(0.17) Estimate, Sales $9.72M Miss $9.91M Estimate",2019-11-07 17:32:00-05:00,CEMI,negative
228313.0,Chembio Diagnostics Receives WHO Prequalification Approval For HIV Self-Test,2019-11-04 08:12:00-05:00,CEMI,positive
228314.0,Chembio Diagnostics Receives WHO Prequalification Approval For Malaysia Facility,2019-10-17 08:10:00-04:00,CEMI,positive
228315.0,Chembio Diagnostics Reports $20M Term Loan With Perceptive Advisors,2019-09-04 08:12:00-04:00,CEMI,neutral
228316.0,Stocks That Hit 52-Week Lows On Monday,2019-08-26 10:28:00-04:00,CEMI,negative
228317.0,"Chembio Diagnostics Q2 EPS $(0.19) Misses $(0.15) Estimate, Sales $9.591M Beat $8.81M Estimate",2019-08-06 17:27:00-04:00,CEMI,negative
228318.0,Chembio Diagnostics And Takeda Pharmaceutical Company Enter Collaboration To Develop Point-Of-Care Diagnostic Test,2019-07-18 08:07:00-04:00,CEMI,neutral
228319.0,"WHO Emergency Committee Meeting To Decide If Ebola Outbreak Constitutes An Int'l. Emergency Will Begin Jun. 14, 2019",2019-06-12 11:15:00-04:00,CEMI,negative
228320.0,"Chembio Diagnostics Q1 EPS $(0.16) Misses $(0.15) Estimate, Sales $8.3M Miss $8.56M Estimate",2019-05-01 16:50:00-04:00,CEMI,negative
228321.0,"Chembio Diagnostics Announces Agreement With Perseus Science To Advance Point-of-Care Concussion Test; Co. Will Receive Funding From Perseus, Satisfying Certain Milestones",2019-04-02 08:05:00-04:00,CEMI,positive
228322.0,Congo Health Ministry Says Has Recorded 15 New Confirmed Cases Of Ebola,2019-03-29 13:55:00-04:00,CEMI,neutral
228323.0,70 Biggest Movers From Friday,2019-03-11 05:26:00-04:00,CEMI,neutral
228324.0,"Chembio Diagnostics Q4 EPS $(0.21) Misses $(0.17) Estimate, Sales $7.6M Beat $7.22M Estimate",2019-03-07 17:00:00-05:00,CEMI,negative
228325.0,"Chembio Diagnostics Wins UNICEF Contract To Supply Point-Of-Care Zika/Chikungunya/Dengue Tests, Micro Readers, No Terms Disclosed",2019-03-07 16:29:00-05:00,CEMI,positive
228326.0,62 Biggest Movers From Yesterday,2019-02-07 04:19:00-05:00,CEMI,neutral
228327.0,Chembio Diagnostics Sees Q4 Sales $7.3M-$7.6M vs $7.05M Estimate; FY18 Sales $33.1M-$33.4M vs $32.7M Est.,2019-02-06 07:32:00-05:00,CEMI,neutral
228328.0,Chembio Diagnostics Receives CE Mark for Point-of-Care Diagnostic Test  Developed in Collaboration with AstraZeneca,2019-01-07 07:20:00-05:00,CEMI,neutral
228329.0,"Benzinga's Top Upgrades, Downgrades For January 4, 2019",2019-01-04 09:14:00-05:00,CEMI,positive
228330.0,"Canaccord Genuity Initiates Coverage On Chembio Diagnostics with Buy Rating, Announces $9 Price Target",2019-01-04 07:39:00-05:00,CEMI,neutral
228331.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,CEMI,neutral
228332.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,CEMI,positive
228333.0,Ebola Outbreak In Eastern Congo Now World's Second Largest Ever With 426 Cases,2018-11-29 15:09:00-05:00,CEMI,neutral
228334.0,Stocks Of Vaccination Providers Do Not React Following Update From Health Ministry Suggesting 13 New Cases Of Ebola Were Reported In Eastern Congo Wed.,2018-11-21 14:43:00-05:00,CEMI,neutral
228335.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018",2018-11-15 11:37:00-05:00,CEMI,negative
228336.0,World Health Organization's Emergency Response Chief Says We Expect Democratic Republic Of Congo's Ebola Outbreak To Last At Least Another Six Months,2018-11-13 10:36:00-05:00,CEMI,negative
228337.0,Chembio Ebola Virus Diagnostic Test Receives U.S. FDA Emergency Use Authorization,2018-11-09 11:14:00-05:00,CEMI,negative
228338.0,"Chembio Diagnostics Shares Tick Higher Above $7 Level, Turn Positive Amid Report FDA Has Allowed Emergency Use For The Co.'s Ebola Fingerstick Test",2018-11-09 10:14:00-05:00,CEMI,positive
228339.0,"Chembio Diagnostics, Inc. Q3 EPS $(0.16) Misses $(0.06) Estimate, Sales $9.4M Beat $9.05M Estimate",2018-11-08 16:19:00-05:00,CEMI,negative
228340.0,76 Biggest Movers From Yesterday,2018-11-02 06:12:00-04:00,CEMI,neutral
228341.0,56 Stocks Moving In Thursday's Mid-Day Session,2018-11-01 12:59:00-04:00,CEMI,neutral
228342.0,35 Stocks Moving In Thursday's Pre-Market Session,2018-11-01 08:04:00-04:00,CEMI,neutral
228343.0,"Chembio Diagnostics Prices 2.37M Share Offering at $6.75/Share, Shares Closed $8.31 Wednesday",2018-11-01 07:44:00-04:00,CEMI,positive
228344.0,"Chembio Diagnostics Announces a Common Stock Offering, Amount Not Disclosed",2018-10-31 16:35:00-04:00,CEMI,neutral
228345.0,66 Biggest Movers From Yesterday,2018-10-26 05:21:00-04:00,CEMI,neutral
228346.0,60 Stocks Moving In Thursday's Mid-Day Session,2018-10-25 12:55:00-04:00,CEMI,neutral
228347.0,Chembio Cancels $25M Common Stock Offering,2018-10-25 08:12:00-04:00,CEMI,negative
228348.0,56 Biggest Movers From Yesterday,2018-10-24 05:53:00-04:00,CEMI,neutral
228349.0,Mid-Afternoon Market Update: Crude Oil Down Over 4%; Therapix Biosciences Shares Spike Higher,2018-10-23 14:40:00-04:00,CEMI,negative
228350.0,44 Stocks Moving In Tuesday's Mid-Day Session,2018-10-23 13:05:00-04:00,CEMI,neutral
228351.0,Mid-Day Market Update: Astec Industries Drops Following Q3 Results; Correvio Pharma Shares Climb,2018-10-23 12:42:00-04:00,CEMI,positive
228352.0,Mid-Morning Market Update: Markets Open Lower; Verizon Earnings Top Estimates,2018-10-23 10:18:00-04:00,CEMI,negative
228353.0,Chembio Reports $25M Common Stock Offering,2018-10-22 17:27:00-04:00,CEMI,neutral
228354.0,Chembio Reports Purchase Of opTricon For $5.5M In Cash,2018-10-22 16:39:00-04:00,CEMI,neutral
228355.0,Chembio Sees Q3 Sales $9.2M-$9.4M vs $8.1M Estimate,2018-10-22 16:39:00-04:00,CEMI,neutral
228356.0,Chembio Diagnostics Wins $10.5M Commitment From Bio-Manguinhos For Production Of DPP Assays In Brazil,2018-10-16 07:04:00-04:00,CEMI,positive
228357.0,30 Stocks Moving In Friday's Pre-Market Session,2018-08-10 08:32:00-04:00,CEMI,neutral
228358.0,"Chembio Diagnostics Q2 EPS $(0.12) Misses $(0.07) Estimate, Sales $8.72M Beat $7.8M Estimate",2018-08-08 17:14:00-04:00,CEMI,negative
228359.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,CEMI,positive
228360.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,CEMI,neutral
228361.0,"The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter",2018-08-02 08:54:00-04:00,CEMI,positive
228362.0,Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test,2018-07-29 07:31:00-04:00,CEMI,neutral
228363.0,"Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering",2018-07-24 08:53:00-04:00,CEMI,positive
228364.0,Stocks Which Set New 52-Week Highs Friday,2018-07-23 11:08:00-04:00,CEMI,neutral
228365.0,Stocks Which Set New 52-Week High Yesterday,2018-07-20 09:05:00-04:00,CEMI,neutral
228366.0,"Benchmark Assumes Chembio Diagnostics at Buy, Announces Price Target $14",2018-07-11 09:44:00-04:00,CEMI,neutral
228367.0,"FDA Announces Revised Guidance On Testing Of Donated Blood, Blood Components For Zika",2018-07-06 10:14:00-04:00,CEMI,neutral
228368.0,"Benzinga's Daily Biotech Pulse: Pain Therapeutics Drops 70%, Neon To Begin Trading",2018-06-27 08:14:00-04:00,CEMI,negative
228369.0,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",2018-05-30 08:14:00-04:00,CEMI,positive
228370.0,"Chembio Diagnostics Reports Agreement with Bio-Manguinhos to Commercialize Point-of-Care Tests for Dengue, Zika and Chikungunya in Brazil",2018-05-24 08:02:00-04:00,CEMI,positive
228371.0,Chembio Diagnostics Enters Non-Binding Memorandum Of Understanding With Massachusetts General Hospital To Develop Point-of-Care Fever Diagnostic Test,2018-05-22 08:13:00-04:00,CEMI,neutral
228372.0,"Chembio Diagnostics Q1 EPS $(0.05) Beats $(0.14) Estimate, Sales $7.717M Beat $6.22M Estimate",2018-05-09 17:22:00-04:00,CEMI,neutral
228373.0,Chembio Diagnostics Reports Collab. Deal With LumiraDx To Develop New POC Diagnostics Tests For Infectious diseases; Chembio Will Receive Funding From LumiraDx Subject To Certain Milestones; Amount Of Payments Not Specified,2018-04-25 08:23:00-04:00,CEMI,positive
228374.0,"Chembio Diagnostics Reports Q4 EPS $(0.16) vs $(0.10) Est., Sales $6M vs $5.71M Est.",2018-03-08 16:27:00-05:00,CEMI,neutral
228375.0,Chembio Diagnostics Prices ~1.784M Share Common Stock Offering At $6.75/Share,2018-02-09 07:01:00-05:00,CEMI,positive
228376.0,"Chembio Diagnostics Announces Common Stock Offering, No Size Disclosed",2018-02-08 17:25:00-05:00,CEMI,negative
228377.0,Chembio Diagnostics Names Neil A. Goldman CFO,2017-12-20 08:51:00-05:00,CEMI,neutral
228378.0,"Chembio Diagnostics, AstraZeneca Report Collaboration To Develop Point-Of-Care Diagnostic Test; Chembio Will Receive Up To $2.9M In Funding",2017-12-19 08:53:00-05:00,CEMI,neutral
228379.0,Chemobio Diagnostics Announces a $8.5M Order From Bio-Manguinhos,2017-12-05 08:51:00-05:00,CEMI,neutral
228380.0,"Chembio Diagnostics Reports Winning Of Potential $4.9M UNICEF Contract To Supply Point-Of-Care DDP Zika Assays, DPP Micro Readers",2017-11-28 08:51:00-05:00,CEMI,positive
228381.0,"Chembio Diagnostics Reports Q3 EPS $(0.05) vs. $(0.19) In Same Qtr. Last Year, Sales $7.6M vs. $3.7M YoY",2017-11-08 16:25:00-05:00,CEMI,neutral
228382.0,8-K From Chembio Diagnostics Shows CFO Richard Larkin To Retire,2017-08-17 17:00:00-04:00,CEMI,neutral
228383.0,"Chembio Diagnostics Reports Q2 Loss/Share $(0.18) vs. $(0.17) Est., Sales $4.11M vs. $5.14M Est.",2017-08-09 16:23:00-04:00,CEMI,neutral
228384.0,Chembio Reports Received Approval For Commercial Use In Brazil Of DPP Micro Reader,2017-07-05 08:51:00-04:00,CEMI,positive
228385.0,10 Biggest Mid-Day Losers For Wednesday,2017-06-28 13:02:00-04:00,CEMI,negative
228386.0,Filing From Chembio Diagnostics Shows Registration For $21.2M Common Stock Offering,2017-06-27 16:18:00-04:00,CEMI,neutral
228387.0,"Acuta Capital Partners Reports 10.3% Passive Stake in Chembio Diagnostics as of May 31, 2017 -13G",2017-06-12 06:08:00-04:00,CEMI,positive
228388.0,Chembio Diagnostics Announces CEO John J. Sperzel III is Taking a Medical Leave of Absence -8-K,2017-05-31 06:07:00-04:00,CEMI,negative
228389.0,"Chembio Diagnostics Reports Q1 EPS $(0.13) vs $(0.20) Est., Sales $6.3M vs $4.6M Est.",2017-05-09 16:59:00-04:00,CEMI,neutral
228390.0,"Chembio Reports Q4 EPS $(0.21) vs $(0.15) Est., Sales $4.25M vs $4.66M Est.",2017-03-07 16:25:00-05:00,CEMI,neutral
228391.0,Chembio's DPP HIV-Syphilis Assay Receives CE Mark for Point-of-Care Detection of HIV and Syphilis,2017-01-17 08:51:00-05:00,CEMI,neutral
228392.0,Chembio Agrees to Acquire Malaysia-based RVR Diagnostics and Establish Operations in Southeast Asia,2016-11-04 08:55:00-04:00,CEMI,positive
228393.0,"Chembio to Acquire Malaysia's RVR Diagnostics and Establish Operations in Southeast Asia for Up to $3.5M in Cash, Stock",2016-11-04 04:10:00-04:00,CEMI,neutral
228394.0,"Chembio Reports Winning of CDC Contract for Zika, Dengue, Chikungunya Surveillance Testing in India, Peru, Guatemala, Haiti; Valued at $330K",2016-09-28 08:52:00-04:00,CEMI,positive
228395.0,Chembio Reports Grant from US Dept. of Ag. to Develop Point of Care Diagnostic Test for Bovine TB,2016-09-26 08:51:00-04:00,CEMI,positive
228396.0,18 Biggest Mid-Day Gainers For Thursday,2016-08-25 12:55:00-04:00,CEMI,neutral
228397.0,Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus,2016-08-25 10:16:00-04:00,CEMI,positive
228398.0,Chembio Reports Expansion of Product Distribution via Exclusive Deal with Isla Lab in Caribbean,2016-08-18 08:52:00-04:00,CEMI,positive
228399.0,Chembio Diagnostics Reports Q2 EPS $(0.86) vs. Prior Year Quarter $(0.07),2016-08-11 08:51:00-04:00,CEMI,neutral
228400.0,Chembio Diagnostics Reports Upsizing of Offering to 2M Shares at $6/Share for Total Gross Proceeds ~$12M,2016-07-29 06:15:00-04:00,CEMI,negative
228401.0,Mid-Afternoon Market Update: Dow Slides Over 100 Points; Sprint Shares Climb Following Q1 Results,2016-07-25 15:22:00-04:00,CEMI,positive
228402.0,10 Biggest Mid-Day Losers For Monday,2016-07-25 13:01:00-04:00,CEMI,negative
228403.0,Mid-Day Market Update: Crude Oil Down 2%; Outerwall Shares Spike Higher,2016-07-25 12:17:00-04:00,CEMI,negative
228404.0,Mid-Morning Market Update: Markets Open Lower; Verizon To Buy Yahoo's Operating Business For $4.8B,2016-07-25 10:04:00-04:00,CEMI,negative
228405.0,Chembio Diagnostics Reports Offering of $10M Common Shares,2016-07-25 08:35:00-04:00,CEMI,positive
228406.0,"Chembio Diagnostics Reports Prelim Q2 Rev. $3.2-$3.3M, Net Loss Of $8.3-$8.5M; Sees 2H 2016 Rev. $8-$10M",2016-07-25 07:47:00-04:00,CEMI,negative
228407.0,"Chembio Diagnostics Reports Launch of US Sales for SURE CHECK HIV 1/2 Assay, Cuts Price of HIV Tests for US Public Health Market",2016-06-01 08:51:00-04:00,CEMI,positive
228408.0,Stocks Hitting 52-Week Highs,2016-05-16 10:04:00-04:00,CEMI,neutral
228409.0,"Chembio Diagnostics Reports Q1 EPS $(0.03) vs. Est. $(0.09), Rev. $6.6M vs. Est. $4.96M",2016-05-12 08:50:00-04:00,CEMI,neutral
228410.0,Chembio and Bio-Manguinhos Announce Plans to Introduce a Point-of-Care Diagnostic Test for Zika Virus in Brazil,2016-05-05 08:57:00-04:00,CEMI,neutral
228411.0,Chembio Awarded $678K Grant To Develop Malaria Oral Fluid/Saliva Diagnostic Test,2016-04-25 08:51:00-04:00,CEMI,positive
228412.0,"Chembio Diagnostics Reports Q4 EPS $(0.07) vs $(0.09) Est., Sales $4.42M vs $6M Est.",2016-03-08 09:46:00-05:00,CEMI,neutral
228413.0,"Earnings Scheduled For March 8, 2016",2016-03-08 04:09:00-05:00,CEMI,neutral
228414.0,"Chembio Diagnostics Reports Q3 EPS $(0.05) VBs Est $(0.07), Revs $6.89M Vs est $6.65M",2015-11-12 08:57:00-05:00,CEMI,positive
228415.0,"Benchmark Initiates Coverage on Chembio Diagnostics at Speculative Buy, Announces $6.00 PT",2015-11-04 07:55:00-05:00,CEMI,positive
228416.0,"Chembio Diagnostics Reports Q2 Loss $0.07 Vs Est $0.00, Sales $6.72M Vs Est $8.10M",2015-08-06 08:51:00-04:00,CEMI,negative
228417.0,Chembio's DPP HIV 1/2 Assay Granted CE Mark Approval for Rapid Point-of-Care Detection of HIV,2015-06-03 09:05:00-04:00,CEMI,positive
228418.0,Chembio's DPP(R) HIV 1/2 Assay Receives CE Mark Approval for Rapid Point-of-Care Detection of HIV,2015-06-03 08:50:00-04:00,CEMI,positive
228419.0,Chembio Launches HIV Self-Testing Kits in Europe,2015-04-29 08:53:00-04:00,CEMI,neutral
228420.0,"Chembio Diagnostics Reports Q4 EPS $(0.05) vs. Est. $(0.03), Rev. $7.09M vs. Est. $7.10M",2015-03-05 08:53:00-05:00,CEMI,neutral
228421.0,13D: Chembio Holder Norman Pessin Reports 6.4% Stake Up From 4.68% In April,2015-02-06 12:39:00-05:00,CEMI,neutral
228422.0,"Chembio Acquires Rights to SURE CHECK HIV 1/2 Assay Effective June 1, 2016",2015-01-22 08:50:00-05:00,CEMI,positive
228423.0,"Chembio Provides Update on DPP Ebola, DPP Febrile Illness Assays",2015-01-12 08:51:00-05:00,CEMI,negative
228424.0,Chembio DPP Technology to be Used in Development of Point-of-Care Diagnostic Test for Traumatic Brain Injury and Sports-Related Concussion,2015-01-06 08:52:00-05:00,CEMI,negative
228425.0,Chembio Signs Agreement With CDC Focused On Influenza Immunity,2014-11-24 08:51:00-05:00,CEMI,positive
228426.0,Chembio Reports DPP(R) HIV 1/2 Assay Receives CLIA Waiver from FDA,2014-10-30 08:54:00-04:00,CEMI,neutral
228427.0,Chembio's DPP(R) HIV 1/2 Assay Receives CLIA Waiver From FDA ,2014-10-30 08:51:00-04:00,CEMI,neutral
228428.0,Shares Of Chembio Falling After Co. Fails To Provide Timeline On Product Deployment,2014-10-28 10:26:00-04:00,CEMI,negative
228429.0,"Chembio Announces Deals to Develop PoC Diagnostic Tests for Dengue Fever, Certain Type of Cancer",2014-10-28 08:52:00-04:00,CEMI,negative
228430.0,Chembio Diagnostics' Stock Suddenly Got Interesting,2014-10-27 12:01:00-04:00,CEMI,positive
228431.0,Morning Market Movers ,2014-10-27 09:55:00-04:00,CEMI,neutral
228432.0,"Chembio Partners With Integrated BioTherapeutics, Inc. To Develop Point-of-Care Diagnostic Tests For Ebola And Febrile Illness",2014-10-27 08:52:00-04:00,CEMI,negative
228433.0,"From 10-Q: Chembio Diagnostics, Inc. Reports Q2 EPS of $(0.02), Inline; Revenue of $7.42M vs $6.02M Est",2014-08-07 08:20:00-04:00,CEMI,neutral
228434.0,Chembio Terminates U.S. Distribution Agreement With Alere ,2014-04-07 08:51:00-04:00,CEMI,positive
228435.0,Chembio's HIV 1/2 Stat-Pak Assay Receives Ce Mark Approval For Rapid Point-Of-Care Detection of JIV,2014-03-25 11:06:00-04:00,CEMI,positive
228436.0,"Chembio Diagnostics, Inc. Reports Q4 EPS of $(0.03) vs $0.04 Est; Revenue of $7.86M vs $7.05M Est",2014-03-06 08:32:00-05:00,CEMI,neutral
228437.0,"Chembio Diagnostics, Inc. Reports Q3 EPS of $0.07 vs $0.08 Est; Revenue of $9.04M vs $8.30M Est",2013-11-07 17:03:00-05:00,CEMI,neutral
228438.0,Stocks Hitting 52-Week Lows,2013-09-05 10:21:00-04:00,CEMI,negative
228439.0,Chembio's SURE CHECK® HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval,2013-06-20 16:02:00-04:00,CEMI,positive
228440.0,Cembio Received $5.3M Purchase Order fo HIV Prevention Plan,2013-06-04 08:54:00-04:00,CEMI,neutral
228441.0,Chembio Appoints Sharon Klugewicz as Chief Operating Officer,2013-05-22 16:12:00-04:00,CEMI,neutral
